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ABSTRAK 
Pendahuluan : K.ronik Rinosinusitis adalah diagnosa otorinolaringologi yang 
utama dan melibatkan 14% daripada populasi am. K.ronik Rinosinusitis adalah 
penyakit populasi am dan telah dikenalpasti menyebabkan kualiti hidup pesakit 
menurun tetapi sehingga kini masih tiada data kuantitatif yang dapat 
menunjukkan kesannya kepada kesihatan kita. Oleh itu, kesahihan, 
kebolehpercayaan dan alat yang responsif seharusnya dibina untuk mengkaji 
impak fizikal, mental, emosi, sosial dan profesional terhadap pesakit kronik 
rinosinusitis terutamanya di Malaysia. 
Objektif: Menterjemah SNOT-22 ke Bahasa Melayu dan seterusnya menilai 
kebolehsanaan, kesahihan dan kebolehpercayaan SNOT -22 versi Bahasa 
Melayu. 
Cara kajian dilaksanakan: Kajian ini merupakan kajian keratan rentas yang 
dijalankan di klinik umum ORL-HNS HUSM. 70 orang responden terlibat. 
SNOT-22 versi Bahasa Melayu dan SF-36 versi Bahasa Melayu yang telah diuji 
kesahihannya dilengkapkan oleh subjek. Proses penterjemahan melibatkan 
terjemahan ke hadapan, ke belakang dan ujian responden. Semakan kesahihan 
muka dan kesahihan kandungan dijalankan. SNOT-22 versi Bahasa Melayu 
diberi sekali lagi dalam tempoh dua ke empat minggu. Analisis meliputi 
penilaian anggapan skala, kebolehsanaan, kesahihan dan kebolehpercayaannya. 
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Keputusan: Mengenai penilaian ujian ini, kadar responsif subjek adalah 97.2% 
dalam penilaian awal dan 100% subjek dalam penilaian semula yang telah 
melengkapkan borang soal-selidik ini. Kesemua item dalam SNOT-22 versi 
Bahasa Melayu mempunyai nilai purata di antara 1.10 - 2.64 .dan sisihan piawai 
dari 0.933- 1.4861. Alpha Cronbach amat tinggi iaitu 0.89 di dalam ujian awal. 
Pekali korelasi intrakelas juga cemerlang iaitu 0.90. Analisis faktor 
menunjukkan kebanyakan item dalam SNOT-22 versi Bahasa Melayu boleh 
dibahagikan kepada 4 subdomain iaitu simptom hidung, telinga atau simptom 
muka, fungsi psikologi dan tidur. Kesahihan kumpulan menunjukkan SNOT-22 
versi Bahasa Melayu boleh membezakan kumpulan kawalan dan pesakit 
(t=15.33; p<0.001). Pemeriksaan kesahihan serentak menunjukkan domain 
Fungsi Fizikal dalam versi Bahasa Melayu SF-36 mempunyai hubungkait secara 
signikan dengan domain simptom telinga atau muka (r=-0.259, p<0.05) dan 
dengan isu psikologi (r=-0.304, p<0.01) di dalam versi Bahasa Melayu SNOT-
22. Domain Kesakitan Badan dalam versi Bahasa Melayu SF-36 (r-0.498, 
p<O.O 1) juga mempunyai kaitan signikan dengan isu psikologi dalam versi 
Bahasa Melayu SNOT-22. Kebanyakan domain di dalam versi Bahasa Melayu 
SF-36 dengan SNOT-22 mempunyai hubungkait yang lemah di antara satu sama 
lain. Tetapi walaupun begitu, kesahihan dan kebolehpercayaan versi Bahasa 
Melayu SNOT -22 sebagai alat yang responsif dalam menentukan kualiti hidup 
pesakit rhinosinusitis dapat ditentukan oleh kesahihan dalam aspek kandungan, 
konstruk dan diskriminan. 
Kesimpulan: Penterjemahan Sino-Nasal Outcome Test 22 (SNOT -22) versi 
Bahasa Melayu boleh diterima Kebolehsanaan dan anggapan skala dipenuhi. 
Kesahan adalah cemerlang dan kebolehpercayaannya dibuktikan. SNOT-22 
XVll 
adalah dicadangkan untuk digunakan oleh doktor dan penyelidik di Malaysia 
sebagai basil ukuran laporan pesakit untuk penyakit sinus dan hidung seperti 
rhinosinusitis dan polyp hidung. 
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ABSTRACT 
Introduction : Chronic rhinosinusitis (CRS) is a major otorhinolaryngology 
diagnosis and affects 14% of the general population. CRS is a disease of general 
population and it has been recognised to affect patient's quality of life but there 
has been no quantitative data that demonstrate the health burden that CRS may 
incur. Thus, valid, reliable and responsive instruments should be developed to 
assess this physical, mental, emotional, social and professional impact on CRS 
patients especially in Malaysia population. 
Objectives: To translate Sino-Nasal Outcome Test-22 into the Malay language 
and to determine the feasibility, validity and reliability of the Malay version of 
SNOT-22. 
Study Design and Methodology : This was a cross sectional study conducted at 
the ORL-HNS general clinic and rhinology clinic in HUSM. 70 CRS 
respondents were involved and 39 healthy participants recruited for the control 
group. The Malay translated SNOT-22 and a previously Malay validated SF-36 
were administered by the respondents. The translation used forward, backward 
and respondent testing and has been reviewed for face and content validity. The 
Malay version of SNOT -22 was administered again at two to four weeks interval 
retesting 55 patients with CRS. The statistical analysis used was feasibility, 
cronbach's alpha, intraclass correlation coefficient, Pearson's correlation 
coefficient and factor analysis. 
XIX 
Results : Regarding feasibility of this test, the response rate of each question 
items was 97.2% in the initial test and 100% in the retest. All items in SNOT-22 
have means ranging from 1.10-2.64 with standard deviations ranged from 0.933-
1.486. The Cronbach's alpha was high that is 0.89 in the initial test. The average 
intraclass correlation coefficient {ICC) was high that is 0.90 indicating good test-
retest reliability. Factor analysis showed that Malay version SNOT -22 have four 
unique constructs that is the rhinological symptoms, ear or facial symptoms, 
sleep and psychological function. Discriminant validity demonstrate that Malay 
version SNOT-22 was able to discriminate between control group and patients 
(t=15.33; p<0.001). Concurrent validity findings showed that the subscale of 
Role Physical (RP) in Malay version SF-36 statistically correlates significantly 
with ear or facial symptoms (r=-0.259, p<0.05) and psychological issues (r=-
0.304, p<0.01) in Malay version SNOT-22. Bodily Pain (BP) domains in Malay 
version SF-36 also statistically significant with psychological issues (r-0.498, 
p<0.01) within Malay version SNOT-22. Most of the domains within Malay 
version SNOT-22 were weakly correlated with the scales of Malay version SF-
36. However, validity of the Malay version SNOT-22 as a reliable and valid tool 
for quality of life assessment is established by fulfillment of content, construct, 
and discriminant validity. 
Conclusions : The translation of the Malay version SNOT -22 was acceptable. 
Feasibility was present and scaling assumptions were met. The reliability was 
excellent and validity is established. SNOT-22 is recommended for Malaysia's 
clinicians and researchers as a patient reported measure of outcome in sino-nasal 







CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
1.1 BACKGROUND OF STUDY 
Chronic Rhinosinusitis (CRS) affects 5-15 % of the urban population in Europe and 
North America (Piccirillo et al., 2002; Mortuaire et al., 2010) with 18 to 22 million 
consultations in the USA (Hessler et al., 2007). The health care cost that was estimated 
was at 2.4 billion USD (Videler et al., 2007). The impact of the illness on the 
socioeconomic burden is significant, whereby it causes the loss of work productivity 
and time off work. Given the consequences and its socioeconomic impact, there has 
been considerable interest in assessing Health Related Quality Of Life (HRQOL) in 
chronic rhinosinusitis patients. Most clinical trials nowadays require outcome 
measures in patients quality of life. 
"Quality of life" expression is rather vague and often means different things to different 
people. Many factors such as finances~ spirituality~ and health contribute to quality of 
life and may affect each other. Subjective well being, fulfillment of social roles and 
functional status are an important domains in medical care and clinical interventions. 
The aim of treatment strategies in each person depends on the relief of symptoms, 
disease progression and improvement of functional capacities. The goal of treatment can 
be achieved if the patient's estimation of his or her well being is taken into account. 
Therefore, before any therapeutic assessment done, one should take into account 
patient's quality of life in addition to traditional biomedical parameters (Siegrist and 
Junge, 1989). 
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Quality of life assessment has increasingly become an important tool in measuring the 
impact of chronic illnesses that is useful for improving patient's health care and in 
clinical trial research (Fayers and Machin, 2000). Recently, there has been increasing 
recognition that the impact of chronic illnesses and the outcome of treatments must be 
measured in terms of their influences on the quality of life together with inclusion of 
traditional indices such as morbidity and mortality (Saxena and Orley, 1997). There 
has been a gradual shift, away from relying on only clinical and laboratory illness 
indicators. The current trend is moving towards incorporation of patient's point of 
view (Wood-Dauphinee, 1999). As a result for increased need to better correlate 
between health care costs and quality of care, outcome measures related to functional 
capacity and well being has gained importance either equal to or greater than analyses 
based on symptoms or biologic and physiologic variables. This includes physical, 
psychological and social aspects, the areas that patients are most interested and 
familiar with (Meltzer et al., 1997). Physiologic measures provide information to 
clinicians, but it is of limited interest to patients because it usually correlates poorly 
with functional capacity and patients well being. Health related quality of life 
(HRQOL) outcomes have become key factors in the development and refinement of 
practise guidelines, the evaluation of patterns of medical care, and the assessment of 
therapeutic interventions (Juniper, 1997; Meltzer et al., 1997). 
HRQOL is defined as ''the functional effects of an illness and its consequent therapy 
upon a patient, as perceived by the patient". The fmal phrase is important because it 
emphasizes the impairments that the patients themselves consider as important (Juniper, 
1997). HRQOL are components of overall quality of life which is determined primarily 
by the person's health and it can be influenced by clinical interventions. 
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Chronic rhinosinusitis (CRS) is extremely common in the general population 
regardless of ethnic background. It is a widespread global health disorder, increasing 
in both incidence and prevalence. It is not a life threatening disorder but it has been 
shown to have significant impact on quality of life (Wang et al., 2003; Hopkins et al., 
2009). However, there has been no quantitative data that may demonstrate health 
burden that CRS may incur (Wang et al., 2003). Thus, valid, reliable and responsive 
instruments should be developed to assess these physical, mental, emotional, social 
and professional impact on CRS patients. Taking into account that each rhinosinusitis 
patients lead a wide range of life styles, having very different personalities, different 
cultural and personal expectations on health and their coping abilities, HRQOL 
outcome may differ markedly even among patients with the same severity of illness, 
thus offering varying potrait of patient's illness (Testa et al., 1996). 
1.2 RHINOSINUSITIS, WHAT IT IS? 
Rhinosinusitis is an inflammatory response involving the mucous membrane of nasal 
cavity and paranasal sinuses. Based on the International Classification of Diseases 
(lCD) - Tenth Revision, rhinosinusitis can be divided into two major groups that is 
acute and chronic. Acute rhinosinusitis is usually infectious in nature as compared to 
chronic disease which resulted from a wide range of processes. 
Chronic Rhinosinusitis is defined as a group of disorder that is characterized by an 
inflammatory reaction of nasal and paranasal sinus mucosa of at least 12 weeks 
consecutively (Wang et al., 2003; Benninger et al., 2003). The Rhinosinusitis Task 
Force of the Sinus and Allergy Health Partnership has decided to use the term 
rhinosinusitis instead of sinusitis. It has been thought that sinusitis is almost always 
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accompanied by concurrent nasal airway inflammation, and usually sinusitis is preceded 
by rhinitis symptoms. Based on this reason, the term rhinosinusitis is used because it 
describes the spectrum of infectious and inflammatory conditions of the nasal and 
paranasal sinus more accurately (Meltzer et al., 2004). 
There has been a lack of consensus regarding definitions and treatments because CRS is 
a spectrum of diseases with a range of appropriate treatments. There is also absence of 
widely accepted definitions for CRS. Recently, there have been multiple suggestions to 
redefme chronic sinus disease according to its pathophysiology and clinical properties. 
1.3 Diagnostic Definition of CRS 
In 1996, the American Academy of Otolaryngology-Head & Neck Surgery 
multidisciplinary Rhinosinusitis Task Force (RTF) defined adult rhinosinusitis 
diagnostic criteria as the presence of two or more 'major' symptoms or one major 
symptom with two or more 'minor' symptoms lasting for 12 or more weeks. 
Following the disagreement regarding the 1996 criteria, in 2003 The Rhinosinusitis 
Task Force updated the definition of CRS by defining the disease as "a group of 
disorders characterized by inflammation of the mucosa of the nose and paranasal 
sinuses of at least 12 consecutive weeks'duration" (Ressel, 2004). The task force 
recommends that all patients who meet with the clinical criteria for CRS to have a CT 
scan or quality photoendoscopy to confirm the diagnosis. 
In this study, the diagnosis of CRS was made according to 2007 European Position 
Paper on Rhinosinusitis and Nasal Polyps (EPOS) criteria which is characterized by 
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presence of two or more cardinal symptoms and presence of either endoscopic signs or 
computed tomography (CT) changes (Table 1.1) (Lange et al., 2011). CT is not an 
option in our study therefore the diagnosis rests on symptoms and nasoendoscopy. 
Table 1.1: CRS Disease Characteristics 
(adapted from Lange et al., 2011) 










Mucosal changes within the osteomeatal 
complex and or sinus 
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